These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3940654)
1. Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Reibnegger GJ; Bichler AH; Dapunt O; Fuchs DN; Fuith LC; Hausen A; Hetzel HM; Lutz H; Werner ER; Wachter H Cancer Res; 1986 Feb; 46(2):950-5. PubMed ID: 3940654 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of neopterin for prognosis and follow-up in ovarian cancer. Reibnegger G; Hetzel H; Fuchs D; Fuith LC; Hausen A; Werner ER; Wachter H Cancer Res; 1987 Sep; 47(18):4977-81. PubMed ID: 3621185 [TBL] [Abstract][Full Text] [Related]
3. Preactivated T cells in cancer patients with poor prognosis. Fuchs DN; Fuith LC; Hausen A; Hetzel H; Reibnegger GJ; Werner ER; Wachter H Cancer Detect Prev; 1988; 12(1-6):97-103. PubMed ID: 3141055 [TBL] [Abstract][Full Text] [Related]
4. Neopterin, a biochemical indicator of cellular immune reactions, in the detection and control of patients with neoplastic diseases. Hausen A; Bichler A; Fuchs D; Hetzel H; Reibnegger G; Wachter H Cancer Detect Prev; 1985; 8(1-2):121-8. PubMed ID: 4064032 [TBL] [Abstract][Full Text] [Related]
5. Neopterin and prognosis in patients with adenocarcinoma of the colon. Weiss G; Kronberger P; Conrad F; Bodner E; Wachter H; Reibnegger G Cancer Res; 1993 Jan; 53(2):260-5. PubMed ID: 8417818 [TBL] [Abstract][Full Text] [Related]
6. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease. Reibnegger G; Fuchs D; Fuith LC; Hausen A; Werner ER; Werner-Felmayer G; Wachter H Cancer Detect Prev; 1991; 15(6):483-90. PubMed ID: 1782638 [TBL] [Abstract][Full Text] [Related]
7. Neopterin as discriminating and prognostic parameter in healthy homosexuals, ARC and AIDS patients. Hutterer J; Fuchs D; Eder G; Hausen A; Knapp W; Köller U; Reibnegger G; Werner ER; Wachter H; Stingl G Wien Klin Wochenschr; 1987 Aug; 99(15):531-5. PubMed ID: 2958970 [TBL] [Abstract][Full Text] [Related]
8. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199 [TBL] [Abstract][Full Text] [Related]
9. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Fuchs D; Weiss G; Reibnegger G; Wachter H Crit Rev Clin Lab Sci; 1992; 29(3-4):307-41. PubMed ID: 1489521 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix. Volgger B; Aspisirengil C; Genser-Krimbacher E; Ciresa-Koenig A; Daxenbichler G; Fuchs D; Windbichler G; Marth C Cancer Lett; 2008 Apr; 262(2):183-9. PubMed ID: 18226853 [TBL] [Abstract][Full Text] [Related]
11. Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels. Strickler HD; Escoffery C; Rattray C; Fuchs D; Wachter H; Manns A; Schiffman MH; Cranston B; Hanchard B; Blattner WA Cancer Epidemiol Biomarkers Prev; 1995; 4(3):295-8. PubMed ID: 7606206 [TBL] [Abstract][Full Text] [Related]
12. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449 [TBL] [Abstract][Full Text] [Related]
14. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659 [TBL] [Abstract][Full Text] [Related]
15. [Urinary excretion of neopterin and plasma levels of interferon gamma in patients with multiple myeloma]. Spicka I; Tomsová Z; Masek Z; Procházka B; Zounar R; Klener P Vnitr Lek; 1996 Oct; 42(10):665-8. PubMed ID: 8975455 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of interleukin-6 and neopterin in patients with multiple myeloma. Reibnegger G; Krainer M; Herold M; Ludwig H; Wachter H; Huber H Cancer Res; 1991 Dec; 51(23 Pt 1):6250-3. PubMed ID: 1933885 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study. Kristensen GB; Holm R; Abeler VM; Tropé CG Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619 [TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery]. Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341 [TBL] [Abstract][Full Text] [Related]
19. [Comment on the article "Immunologic aspects of invasive squamous cell carcinoma of the cervix uteri"]. Fuith LC; Hetzel H; Reibnegger G; Wachter H; Dapunt O Geburtshilfe Frauenheilkd; 1988 Jun; 48(6):466-7. PubMed ID: 3262073 [No Abstract] [Full Text] [Related]
20. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms]. Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]